1. For « expected events », the best approach is to stockpile (« no delay » between identification and implementation of field vaccination) 1.1 However, this is associated with costs, technical issues, and uncertainties... 2. For « unexpected events », all timelines become highly critical: 2.1 Identification of pathogen / immunogen is key 2.2 « Quality by Design » of the optimal vaccine for « instant » manufacturing capacities.
展开▼